Ping Yan

660 total citations
42 papers, 550 citations indexed

About

Ping Yan is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Ping Yan has authored 42 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Cancer Research. Recurrent topics in Ping Yan's work include Radiopharmaceutical Chemistry and Applications (11 papers), RNA Interference and Gene Delivery (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Ping Yan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), RNA Interference and Gene Delivery (10 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Ping Yan collaborates with scholars based in China, Russia and Switzerland. Ping Yan's co-authors include Tao Shao, В. Ф. Тарасенко, Е. Х. Бакшт, Zheng Niu, Chunli Zhang, Rongfu Wang, Meng Liu, Ming Yu, Cheng Zhang and Rong Fu Wang and has published in prestigious journals such as Applied Physics Letters, PLoS ONE and Molecules.

In The Last Decade

Ping Yan

38 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Yan China 12 276 220 159 55 54 42 550
Hea Min Joh South Korea 16 625 2.3× 498 2.3× 100 0.6× 27 0.5× 69 1.3× 24 777
David Brasse France 17 296 1.1× 114 0.5× 145 0.9× 76 1.4× 28 0.5× 71 791
Yansheng Jiang Belgium 12 89 0.3× 80 0.4× 46 0.3× 38 0.7× 25 0.5× 29 414
Joey De Backer Belgium 12 352 1.3× 131 0.6× 186 1.2× 21 0.4× 36 0.7× 17 554
Feiyu Chen China 13 288 1.0× 51 0.2× 80 0.5× 39 0.7× 10 0.2× 35 637
Fuxiang Liu China 8 332 1.2× 224 1.0× 59 0.4× 20 0.4× 20 0.4× 20 490
Joachim Lutz Germany 12 61 0.2× 125 0.6× 112 0.7× 14 0.3× 50 0.9× 28 454
Christian Siebenwirth Germany 14 233 0.8× 83 0.4× 231 1.5× 32 0.6× 12 0.2× 25 668
Narasimhan Rajaram United States 21 499 1.8× 97 0.4× 310 1.9× 177 3.2× 25 0.5× 66 1.4k

Countries citing papers authored by Ping Yan

Since Specialization
Citations

This map shows the geographic impact of Ping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Yan more than expected).

Fields of papers citing papers by Ping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Yan. The network helps show where Ping Yan may publish in the future.

Co-authorship network of co-authors of Ping Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Yan. A scholar is included among the top collaborators of Ping Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Yan. Ping Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Zhao, Xiaojiang Duan, Ping Yan, et al.. (2022). 99mTc-labeled peptide targeting interleukin 13 receptor α 2 for tumor imaging in a cervical cancer mouse model. Annals of Nuclear Medicine. 36(4). 360–372. 4 indexed citations
3.
Yan, Ping, Chunli Zhang, Xiaojiang Duan, et al.. (2021). Arginine–Arginine–Leucine Peptide Targeting Heat Shock Protein 70 for Cancer Imaging. Molecular Pharmaceutics. 18(10). 3750–3762. 1 indexed citations
4.
Pan, Hao, et al.. (2020). Expression and pathogenesis of VCAM-1 and VLA-4 cytokines in multiple myeloma. Saudi Journal of Biological Sciences. 27(6). 1674–1678. 6 indexed citations
5.
Huo, Yan, Lei Kang, Ping Yan, et al.. (2018). Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models. Molecular Imaging and Biology. 21(2). 286–296. 8 indexed citations
6.
7.
Liu, Meng, Rong Fu Wang, Ping Yan, et al.. (2017). Noninvasive imaging of c(RGD)2‐9R as a potential delivery carrier for transfection of siRNA in malignant tumors. Journal of Labelled Compounds and Radiopharmaceuticals. 60(9). 385–393. 3 indexed citations
8.
Li, Ling, Chunli Zhang, Lei Kang, et al.. (2015). Enhanced EJ Cell Killing of 125 I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive Promoter. Cancer Biotherapy and Radiopharmaceuticals. 30(8). 342–348. 1 indexed citations
9.
Li, Ling, Chunli Zhang, Ping Yan, et al.. (2014). Effects of radiation-induced suicide gene therapy under radiation of radionuclide 125I on human hepatocarcinoma cells in vitro. Chinese Medical Journal. 127(7). 1385–1387.
10.
Yan, Ping, et al.. (2014). High Monocarboxylate Transporter 4 Protein Expression in Stromal Cells Predicts Adverse Survival in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 15(20). 8923–8929. 14 indexed citations
11.
Zhang, Xiao, et al.. (2014). Downregulation of KDR expression induces apoptosis in breast cancer cells. Cellular & Molecular Biology Letters. 19(4). 527–41. 17 indexed citations
12.
Kang, Lei, Xiaojie Xu, Rongfu Wang, et al.. (2014). Optimized Preparation of a 99mTc-Radiolabeled Probe for Tracing MicroRNA. Cell Biochemistry and Biophysics. 71(2). 905–912. 5 indexed citations
13.
Zhao, Qian, Ping Yan, Rong Fu Wang, et al.. (2013). A Novel 99mTc-Labeled Molecular Probe for Tumor Angiogenesis Imaging in Hepatoma Xenografts Model: A Pilot Study. PLoS ONE. 8(4). e61043–e61043. 9 indexed citations
14.
Wald, Noémie, Ping Yan, Claus Meyer, et al.. (2013). Breast cancer and melanoma cell line identification by FTIR imaging after formalin-fixation and paraffin-embedding. The Analyst. 138(14). 4083–4083. 44 indexed citations
15.
Yin, Lei, Qian Zhao, Ling Li, et al.. (2013). An Experimental Study on 131I-CHIBA-1001: A Radioligand for α7 Nicotinic Acetylcholine Receptors. PLoS ONE. 8(7). e70188–e70188. 6 indexed citations
16.
Xia, Lu, Ping Yan, Rongfu Wang, et al.. (2012). Use of radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging. Chinese Journal of Cancer Research. 24(1). 52–59. 7 indexed citations
17.
Xia, Lu, Ping Yan, Rongfu Wang, et al.. (2011). The further study on radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging. Journal of Radioanalytical and Nuclear Chemistry. 290(3). 623–630. 7 indexed citations
18.
Yan, Ping. (2010). Cellular Uptake Study on Radiolabeled Telomerase-targeted Small Interference RNA in Hepatocarcinoma Cells. Journal of Oncology. 1 indexed citations
19.
Kang, Lei, Rong Fu Wang, Ping Yan, et al.. (2010). Noninvasive Visualization of RNA Delivery with 99mTc-Radiolabeled Small-Interference RNA in Tumor Xenografts. Journal of Nuclear Medicine. 51(6). 978–986. 23 indexed citations
20.
Liu, Meng, et al.. (2007). Noninvasive Imaging of Human Telomerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTc-Radiolabeled Antisense Probes in Malignant Tumors. Journal of Nuclear Medicine. 48(12). 2028–2036. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026